332 related articles for article (PubMed ID: 11555849)
1. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and IGF-I/IGFBP-3 ratio measurements and their relationship with an index of clinical activity in the management of patients with acromegaly.
Páramo C; Andrade O MA; Fluiters E; Luna R; de la Fuente J; García-Mayor RV
Metabolism; 1997 May; 46(5):494-8. PubMed ID: 9160813
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
6. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
Chen HS; Lin HD
J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
[TBL] [Abstract][Full Text] [Related]
7. A comparison of different methods for diagnosing acromegaly.
Stoffel-Wagner B; Springer W; Bidlingmaier F; Klingmüller D
Clin Endocrinol (Oxf); 1997 May; 46(5):531-7. PubMed ID: 9231047
[TBL] [Abstract][Full Text] [Related]
8. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
[TBL] [Abstract][Full Text] [Related]
9. High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization.
Parkinson C; Flyvbjerg A; Trainer PJ
Growth Horm IGF Res; 2004 Feb; 14(1):59-65. PubMed ID: 14700556
[TBL] [Abstract][Full Text] [Related]
10. The role of IGF binding protein-3 as a parameter of activity in acromegalic patients.
Halperin I; Casamitjana R; Flores L; Fernandez-Balsells M; Vilardell E
Eur J Endocrinol; 1999 Aug; 141(2):145-8. PubMed ID: 10427158
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
12. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Fukuda I; Hizuka N; Itoh E; Yasumoto K; Ishikawa Y; Murakami Y; Sata A; Takano K
Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
Inoue-Lima TH; Vasques GA; Nakaguma M; Brito LP; Mendonça BB; Arnhold IJP; Jorge AAL
Horm Res Paediatr; 2020; 93(3):197-205. PubMed ID: 32799208
[TBL] [Abstract][Full Text] [Related]
15. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
Thissen JP; Ketelslegers JM; Maiter D
Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
Renehan AG; Toogood AA; Ryder WD; Jones J; Potten CS; O'Dwyer ST; Shalet SM
Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance.
Kocyigit Y; Bayhan G; Atamer A; Atamer Y
Gynecol Endocrinol; 2004 Jun; 18(6):341-8. PubMed ID: 15497497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
